
View larger version (46K):
[in this window]
[in a new window]
|
Fig. 1. RalA is required for neuronal polarity. (A) Cortical neurons stained for RalA and neuron-specific β-III tubulin 48 hours after nucleofection of control (top) or RalA siRNA (centre). Control cells positive for RalA display a polarized morphology, whereas a considerable portion of RalA-depleted cells lacks a major process. These RalA-depleted cells (visualized by co-transfection of GFP with RalA siRNA) are not polarized, as shown by lack of tau-1 staining (bottom, arrowhead). The arrow indicates a tau-1-positive axon of an untransfected cell. Scale bars: 40 µm. (B) (Left) Quantification of polarization in cortical neurons 48 hours after nucleofection of control or RalA siRNA (mean ± s.e.m.: control siRNA, 74.53±0.87; RalA siRNA, 41.77±3.53; ***P<0.001). (Centre) Quantification of minor neurite length in control and RalA siRNA (mean ± s.e.m.: control siRNA, 26.80±0.87; RalA siRNA, 58.70±1.70; ***P<0.001). (Right) Active RalA levels increase at early stages of polarization. Neurons were lysed at the indicated time points after plating and assayed for active RalA levels by a Ral-GTP pull down. A representative blot is shown (top), together with data quantification (bottom; mean ± s.e.m.: 10 hours, 1.88±0.36; 24 hours, 1.66±0.29; *P<0.05). (C) At early stages of neuronal polarization (10 hours), RalA concentrates in one emerging neurite tip before PAR-3 (top row, arrowheads). Partial colocalization of RalA with PAR-3 at axon tips shown by a confocal section of a polarized neuron at later times (24 hours) (bottom row, arrowheads). Insets show a magnification of the axon growth cone. Scale bars: 20 µm. (D) Cortical neurons nucleofected with GFP, myc-tagged dominant-negative (RalA28N) or constitutively active (RalA72L) RalA, or an HA-tagged constitutively active RalGEF (Rlf-CAAX) stained with anti-myc or anti-HA and anti-tau-1 (right) antibodies 24 hours after plating. GFP-expressing neurons have a tau-1-positive axon (top row), whereas many cells transfected with Ral mutants or Rlf-CAAX lack tau-1 staining (arrowheads). Arrows indicate tau-1-positive axons of untransfected cells. Scale bar: 40 µm. (E) Quantification of the neuronal polarity defect (mean ± s.e.m.: GFP, 57.47±2.22; RalA28N, 34.23±0.67; RalA72L, 19.6±2.46; Rlf-CAAX, 24.53±5.42; **P<0.01). (F) Cortical neurons nucleofected with GFP or the indicated myc-tagged RalA constructs stained with anti-myc antibody 24 hours after nucleofection. Cells expressing constitutively active RalA (RalA72L) show an unpolarized phenotype also observed in cells expressing the active RalA mutants unable to interact with RalBP1 (RalA72LD49N) or with PLD (RalA72L N11). By contrast, neurons expressing the active RalA mutant unable to interact with the exocyst complex (RalA72LD49E) display a polarized morphology. Scale bar: 20 µm. (G) (Top) Quantification of the polarity defect in neurons expressing the indicated constructs (mean ± s.e.m.: GFP, 67.12±2.36; RalA72L, 24.63±2.57; RalA72LD49N, 30.83±3.43; RalA72LD49E, 65.6±2.20; RalA72L N11, 30.55±3.89; ***P<0.001). (Bottom) Western blot analysis shows similar expression levels of the myc-tagged RalA constructs.
|